已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Genetic and Epigenetic Alterations in Primary–Progressive Paired Oligodendroglial Tumors

作者
Lu‐Ting Kuo,Shao‐Yu Tsai,Cheng‐Chi Chang,Kuan‐Ting Kuo,Abel Po‐Hao Huang,Jui‐Chang Tsai,Ham-Min Tseng,Meng‐Fai Kuo,Yong‐Kwang Tu
出处
期刊:PLOS ONE [Public Library of Science]
卷期号:8 (6): e67139-e67139 被引量:8
标识
DOI:10.1371/journal.pone.0067139
摘要

The aim of the present study was to identify genetic and epigenetic alterations involved in the progression of oligodendroglial tumors. We characterized 21 paired, World Health Organization (WHO) grade II and III oligodendroglial tumors from patients who received craniotomies for the partial or complete resection of primary and secondary oligodendroglial tumors. Tumor DNA was analyzed for alterations in selected genetic loci (1p36, 9p22, 10q23-24, 17p13, 19q13, 22q12), isocitrate dehydrogenase 1 (IDH1), isocitrate dehydrogenase 2 (IDH2) and the CpG island methylation status of critical tumor-related genes (MGMT, P16, DAPK, PTEN, RASSF1A, Rb1). Alterations of these markers were common early in the tumorigenesis. In the primary tumors we identified 12 patients (57.1%) with 1p36 deletions, 17 (81.0%) with 19q13 deletions, 9 (42.9%) with 1p36/19q13 codeletions, 11 (52.3%) with 9p22 deletions, and 12 (57.1%) with IDH1 mutation. Epigenetic analysis detected promoter methylation of the MGMT, P16, DAPK, PTEN, RASSF1A, and Rb1 genes in 38.1%, 19.0%, 38.1%, 33.3%, 66.7%, and 14.3% of primary tumors, respectively. After progression, additional losses of 1p, 9p, 10q, 17p, 19q and 22q were observed in 3 (14.3%), 1 (4.8%), 3 (14.3%), 2 (9.5%), 1 (4.8%) and 3 (14.3%) cases, respectively. Additional methylations of the MGMT, P16, DAPK, PTEN, RASSF1A, and RB1 promoters was observed in 4 (19.0%), 2 (9.5%), 0 (0%), 6 (28.6%), 2(9.5%) and 3 (14.3%) cases, respectively. The status of IDH1 mutation remained unchanged in all tumors after progression. The primary tumors of three patients with subsequent progression to high-grade astrocytomas, all had 9p deletion, intact 1p, intact 10q and unmethylated MGMT. Whether this may represent a molecular signature of patients at-risk for the development of aggressive astrocytomas needs further investigation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
WangZD发布了新的文献求助10
1秒前
科研通AI2S的应助被科研通管家采纳,获得10
1秒前
搜集达人的应助被科研通管家采纳,获得10
1秒前
852的应助被科研通管家采纳,获得10
1秒前
无花果的应助被科研通管家采纳,获得10
1秒前
星辰大海的应助被科研通管家采纳,获得10
1秒前
CodeCraft的应助被科研通管家采纳,获得10
1秒前
2秒前
英俊的铭的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
科研通AI2S的应助被科研通管家采纳,获得10
2秒前
慕青的应助被科研通管家采纳,获得10
2秒前
2秒前
852的应助被科研通管家采纳,获得10
2秒前
3秒前
赘婿的应助被科研通管家采纳,获得10
3秒前
Owen的应助被科研通管家采纳,获得10
3秒前
菜菜的树完成签到,获得积分10
3秒前
Maestro_S的应助被科研通管家采纳,获得10
3秒前
DW的应助被科研通管家采纳,获得10
3秒前
今后的应助被科研通管家采纳,获得10
3秒前
风吹麦浪的应助被科研通管家采纳,获得10
3秒前
4秒前
4秒前
汉堡包的应助被科研通管家采纳,获得10
4秒前
qducly2026的应助被科研通管家采纳,获得200
4秒前
wanci的应助被科研通管家采纳,获得10
4秒前
null的应助被科研通管家采纳,获得10
4秒前
4秒前
鹅鹅完成签到 ,获得积分20
5秒前
李健的应助被羊咩咩采纳,获得10
6秒前
慕青的应助被生动的电脑采纳,获得10
6秒前
顏泰楊完成签到,获得积分10
6秒前
6秒前
所所的应助被科研小白采纳,获得10
6秒前
Bai发布了新的文献求助10
6秒前
8秒前
8秒前
秃头泡泡完成签到 ,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179198
求助须知:如何正确求助?哪些是违规求助? 9569781
关于积分的说明 21806509
捐赠科研通 7774542
什么是DOI,文献DOI怎么找? 3433008
关于科研通互助平台的介绍 2556929
邀请新用户注册赠送积分活动 2478652